ciprofloxacin has been researched along with Mycobacterium Infections in 39 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Mycobacterium Infections: Infections with bacteria of the genus MYCOBACTERIUM.
Excerpt | Relevance | Reference |
---|---|---|
"Achalasia is a common adult disorder that rarely manifests in children and infrequently can be associated with pulmonary nontuberculous mycobacteria infections." | 1.37 | Achalasia and mycobacterium goodii pulmonary infection. ( Borrás-Salvador, R; Franco, J; Martí-Obiol, R; Martínez-González, D; Muñoz, C; Navarro-Ortega, D, 2011) |
"Treatment with ciprofloxacin and linezolid was started on the basis of the antibiogram findings." | 1.34 | Successful recovery after disseminated infection due to mycobacterium abscessus in a lung transplant patient: subcutaneous nodule as first manifestation--a case report. ( Blanes, M; Morales, P; Pérez-Enguix, D; Ros, JA; Saiz, V; Santos, M, 2007) |
"Peritonitis is a major complication of peritoneal dialysis (PD)." | 1.33 | Mycobacterium simiae: a previously undescribed pathogen in peritoneal dialysis peritonitis. ( Jeyaratnam, D; Keenan, N; Sheerin, NS, 2005) |
" The interactions between antibiotic treatment and cyclosporine therapy should be observed closely in organ transplant recipients, requiring frequent level determinations and dosing changes." | 1.33 | Successful management of two heart transplant recipients with mycobacterial pulmonary infections. ( Barten, M; Bittner, HB; Bossert, T; Gummert, JF; Mohr, FW; Rahmel, A; Richter, M, 2005) |
"Treatment with clarithromycin (50 mg/kg/day sc) and rifabutin (20 mg/kg/day po) was found to decrease the bacterial counts in the spleens significantly as early as 15 days after the onset of treatment (P < 0." | 1.30 | Treatment of disseminated Mycobacterium genavense infection in a murine model with ciprofloxacin, amikacin, ethambutol, clarithromycin and rifabutin. ( Kerharo, G; Matsiota-Bernard, P; Nauciel, C; Vrioni, G, 1998) |
" Adverse events, premature discontinuation of therapy, and deaths occurred at a similar frequency in both treatment arms." | 1.30 | Safety of long-term therapy with ciprofloxacin: data analysis of controlled clinical trials and review. ( Haverstock, D; Reinhart, H; Segev, S; Yaniv, I, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (7.69) | 18.7374 |
1990's | 17 (43.59) | 18.2507 |
2000's | 11 (28.21) | 29.6817 |
2010's | 8 (20.51) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fernández-Roblas, R | 2 |
Martín-de-Hijas, NZ | 2 |
Fernández-Martínez, AI | 1 |
García-Almeida, D | 1 |
Gadea, I | 2 |
Esteban, J | 2 |
Patsche, CB | 1 |
Svensson, E | 1 |
Wejse, C | 1 |
de Miguel-Martinez, I | 1 |
Lorenzo-Garde, L | 1 |
Cañas-Hernandez, F | 1 |
Yoo, DK | 1 |
Hosseini-Moghaddam, SM | 1 |
Schumacher, O | 1 |
Dabernig, J | 1 |
Nenadic, I | 1 |
Ingianni, G | 1 |
Cedidi, C | 1 |
Ortiz, A | 1 |
Kinnari, TJ | 1 |
Bodas Sánchez, A | 1 |
Castro-Silva, AN | 1 |
Freire, AO | 1 |
Grinbaum, RS | 1 |
Elmor de Araújo, MR | 1 |
Abensur, H | 1 |
Araújo, MR | 1 |
Romão, JE | 1 |
Sampaio, JL | 1 |
Noronha, IL | 1 |
Martínez-González, D | 1 |
Franco, J | 1 |
Navarro-Ortega, D | 1 |
Muñoz, C | 1 |
Martí-Obiol, R | 1 |
Borrás-Salvador, R | 1 |
Monego, F | 1 |
Duarte, RS | 1 |
Biondo, AW | 1 |
Govendir, M | 1 |
Norris, JM | 1 |
Hansen, T | 1 |
Wigney, DI | 1 |
Muscatello, G | 1 |
Trott, DJ | 1 |
Malik, R | 1 |
Kay, MK | 1 |
Perti, TR | 1 |
Duchin, JS | 1 |
Kunin, M | 1 |
Salamon, F | 1 |
Weinberger, M | 1 |
Genkin, I | 1 |
Sagie, A | 1 |
Tur-Kaspa, R | 1 |
Keenan, N | 1 |
Jeyaratnam, D | 1 |
Sheerin, NS | 1 |
Bossert, T | 1 |
Bittner, HB | 1 |
Richter, M | 1 |
Rahmel, A | 1 |
Barten, M | 1 |
Gummert, JF | 1 |
Mohr, FW | 1 |
Thorell, EA | 1 |
Sharma, M | 2 |
Jackson, MA | 1 |
Selvarangan, R | 1 |
Woods, GM | 1 |
Morales, P | 1 |
Ros, JA | 1 |
Blanes, M | 1 |
Pérez-Enguix, D | 1 |
Saiz, V | 1 |
Santos, M | 1 |
Forslund, T | 1 |
Rummukainen, M | 1 |
Kousa, M | 1 |
Krees, R | 1 |
Relander, A | 1 |
Katila, ML | 1 |
Artenstein, AW | 1 |
Fritzinger, D | 1 |
Gasser, RA | 1 |
Skillman, LP | 1 |
McEvoy, PL | 1 |
Hadfield, TL | 1 |
Spiegl, PV | 1 |
Feiner, CM | 1 |
Hoffner, SE | 1 |
Klintz, L | 1 |
Olsson-Liljequist, B | 1 |
Bolmström, A | 1 |
Toth, EL | 1 |
Boychuk, LR | 1 |
Kirkland, PA | 1 |
Atkinson, BA | 1 |
Bocanegra, R | 1 |
Graybill, JR | 1 |
Hachem, R | 1 |
Raad, I | 1 |
Rolston, KV | 1 |
Whimbey, E | 1 |
Katz, R | 1 |
Tarrand, J | 1 |
Libshitz, H | 1 |
Fisher, M | 1 |
Tomlinson, DR | 1 |
Coker, RJ | 1 |
Macías, J | 1 |
Pineda, JA | 1 |
Borderas, F | 1 |
Gallardo, JA | 1 |
Delgado, J | 1 |
Leal, M | 1 |
Sánchez-Quijano, A | 1 |
Lissen, E | 1 |
Benator, DA | 1 |
Kan, V | 1 |
Gordin, FM | 1 |
Padeĭskaia, EN | 1 |
Vrioni, G | 1 |
Nauciel, C | 1 |
Kerharo, G | 1 |
Matsiota-Bernard, P | 1 |
Segev, S | 1 |
Yaniv, I | 1 |
Haverstock, D | 1 |
Reinhart, H | 1 |
Fang, CT | 1 |
Chang, SC | 1 |
Luh, KT | 1 |
Chang, YL | 1 |
Hsueh, PR | 1 |
Hsieh, WC | 1 |
Wolfe, J | 1 |
Turenne, C | 1 |
Alfa, M | 1 |
Harding, G | 1 |
Thibert, L | 1 |
Kabani, A | 1 |
Truant, AL | 1 |
Conaron, J | 1 |
Moghaddas, J | 1 |
Sethi, S | 1 |
Ray, P | 1 |
Singh, M | 1 |
Gupta, A | 1 |
McBride, ME | 1 |
Rudolph, AH | 1 |
Tschen, JA | 1 |
Cernoch, P | 1 |
Davis, J | 1 |
Brown, BA | 2 |
Wallace, RJ | 2 |
Bedsole, G | 1 |
Sumter, G | 1 |
Sanders, CV | 1 |
Steele, LC | 1 |
Smith, J | 1 |
Graham, DR | 1 |
Westmoreland, D | 1 |
Woodwards, RT | 1 |
Holden, PE | 1 |
James, PA | 1 |
Collins, CH | 1 |
Uttley, AH | 1 |
Saito, H | 1 |
Sato, K | 1 |
Tomioka, H | 1 |
Watanabe, T | 1 |
Masur, H | 1 |
Tuazon, C | 1 |
Gill, V | 1 |
Grimes, G | 1 |
Baird, B | 1 |
Fauci, AS | 1 |
Lane, HC | 1 |
4 reviews available for ciprofloxacin and Mycobacterium Infections
Article | Year |
---|---|
Conservative treatment of prosthetic valve endocarditis due to Mycobacterium fortuitum.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Endocarditis, Bacterial; Heart Valve Prosthesi | 2002 |
Mycobacterium szulgai infection of the lung: case report and review of an unusual pathogen.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Lung | 1997 |
[Value of ciprofloxacin in the therapy of tuberculosis and other mycobacterioses].
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium | 1997 |
Successful treatment of disseminated Mycobacterium szulgai infection with ciprofloxacin, rifampicin, and ethambutol.
Topics: Adolescent; Aged; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Drug Therapy, C | 1999 |
35 other studies available for ciprofloxacin and Mycobacterium Infections
Article | Year |
---|---|
In vitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivit | 2008 |
Disseminated Mycobacterium celatum disease with prolonged pulmonary involvement.
Topics: Aged; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; | 2014 |
[Bacteriemia due to Mycobacterium canariasense in an oncohematological patient with a long-term central device].
Topics: Aged; Bacteremia; Bacterial Typing Techniques; Catheter-Related Infections; Catheterization, Central | 2014 |
Pacemaker pocket infection due to Mycobacterium goodii, a rapidly growing mycobacteria.
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Doxycycline; Drug Resistance, Bacterial; Drug Therapy, C | 2017 |
[Severe course of a rare non-tuberculous Mycobacteriosis (M. haemophilum) of the hand - case report and strategic comments].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Debridement; Drug Thera | 2008 |
Detection of lfrA and tap efflux pump genes among clinical isolates of non-pigmented rapidly growing mycobacteria.
Topics: Anti-Bacterial Agents; Antiporters; Bacterial Proteins; Ciprofloxacin; DNA Primers; DNA, Bacterial; | 2009 |
Cutaneous Mycobacterium haemophilum infection in a kidney transplant recipient after acupuncture treatment.
Topics: Acupuncture Therapy; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Humans; Immunocompromised | 2011 |
Achalasia and mycobacterium goodii pulmonary infection.
Topics: Adolescent; Anti-Bacterial Agents; Bronchopneumonia; Ciprofloxacin; Doxycycline; Esophageal Achalasi | 2011 |
gyrA and gyrB gene mutation in ciprofloxacin-resistant Mycobacterium massiliense clinical isolates from Southern Brazil.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Typing Tec | 2012 |
Susceptibility of rapidly growing mycobacteria and Nocardia isolates from cats and dogs to pradofloxacin.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Ciprofloxacin; Dog Diseases; Dogs; Enrofloxacin; | 2011 |
Tattoo-associated Mycobacterium haemophilum skin infection in immunocompetent adult, 2009.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Contact Tracing; Drug Therapy, Combinat | 2011 |
Mycobacterium simiae: a previously undescribed pathogen in peritoneal dialysis peritonitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Amikacin; Amoxicillin; Antiretroviral Therapy, Highly | 2005 |
Successful management of two heart transplant recipients with mycobacterial pulmonary infections.
Topics: Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Heart Failure; Heart Tr | 2005 |
Disseminated nontuberculous mycobacterial infections in sickle cell anemia patients.
Topics: Acetamides; Adolescent; Amikacin; Anemia, Sickle Cell; Anti-Bacterial Agents; Cefoxitin; Ciprofloxac | 2006 |
Successful recovery after disseminated infection due to mycobacterium abscessus in a lung transplant patient: subcutaneous nodule as first manifestation--a case report.
Topics: Acetamides; Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cystic Fibrosis | 2007 |
Disseminated cutaneous infection due to Mycobacterium chelonae in a patient with rheumatoid arthritis, amyloidosis, and renal failure.
Topics: Amyloidosis; Anti-Bacterial Agents; Anti-Infective Agents; Arthritis, Rheumatoid; Biopsy; Ciprofloxa | 1995 |
Infection due to Mycobacterium haemophilum identified by whole cell lipid analysis and nucleic acid sequencing.
Topics: Abscess; Aged; Ciprofloxacin; DNA, Bacterial; DNA, Ribosomal; Drug Therapy, Combination; Fatty Acids | 1994 |
Mycobacterium phlei infection of the foot: a case report.
Topics: Biopsy; Ciprofloxacin; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Foot Dise | 1994 |
Evaluation of Etest for rapid susceptibility testing of Mycobacterium chelonae and M. fortuitum.
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Evaluation Studies | 1994 |
Recurrent infection of continuous subcutaneous insulin infusion sites with Mycobacterium fortuitum.
Topics: Anti-Bacterial Agents; Blood Glucose; Cefoxitin; Ciprofloxacin; Diabetes Mellitus, Type 1; Drug Ther | 1995 |
Treatment of Mycobacterium haemophilum infection in a murine model with clarithromycin, rifabutin, and ciprofloxacin.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Drug Therapy, | 1995 |
Cutaneous and pulmonary infections caused by Mycobacterium vaccae.
Topics: Aged; Animals; Anti-Bacterial Agents; Cattle; Ciprofloxacin; Humans; Male; Middle Aged; Minocycline; | 1996 |
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group.
Topics: Adrenal Cortex Hormones; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitu | 1996 |
Rhodococcus or mycobacterium? An example of misdiagnosis in HIV infection.
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromy | 1997 |
Treatment of disseminated Mycobacterium genavense infection in a murine model with ciprofloxacin, amikacin, ethambutol, clarithromycin and rifabutin.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; | 1998 |
Safety of long-term therapy with ciprofloxacin: data analysis of controlled clinical trials and review.
Topics: Arthritis, Reactive; Ciprofloxacin; Consumer Product Safety; Humans; Inflammatory Bowel Diseases; My | 1999 |
Mycobacterium branderi from both a hand infection and a case of pulmonary disease.
Topics: Chromatography, High Pressure Liquid; Ciprofloxacin; Clarithromycin; DNA, Ribosomal; Drug Therapy, C | 2000 |
Effect of pre-stain viability on the acid-fast staining characteristics of Mycobacterium species.
Topics: Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Hot Temperature; Humans; Mycobact | 2001 |
Mycobacterium fortuitum wound infection following laparoscopy.
Topics: Amikacin; Ciprofloxacin; Cross Infection; Humans; Laparoscopy; Mycobacterium fortuitum; Mycobacteriu | 2001 |
Diagnostic and therapeutic considerations for cutaneous Mycobacterium haemophilum infections.
Topics: Aged; Ciprofloxacin; Female; Forearm; Humans; Mycobacterium; Mycobacterium Infections; Skin Diseases | 1991 |
Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy.
Topics: Adult; Aged; Ciprofloxacin; Drug Resistance, Microbial; Female; Humans; Male; Microbial Sensitivity | 1990 |
Soft tissue abscess caused by Mycobacterium fortuitum.
Topics: Abscess; Adult; Cefoxitin; Ciprofloxacin; Connective Tissue Diseases; Humans; Male; Mycobacterium In | 1990 |
In-vitro susceptibility of mycobacteria to ciprofloxacin.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Culture Media; Drug Resistance, Microbial; Microbial Sensitivi | 1985 |
[In vitro and in vivo activities of norfloxacin, ofloxacin and ciprofloxacin against various mycobacteria].
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Female; Mice; Mycobacteri | 1987 |
Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clofazimine; Cyc | 1987 |